COGT · Cogent Biosciences Inc. Common Stock
View on chartInsiders & Stakes
| Fairmount Funds Management LLC Director | ▼ Sell | Open Market | 5,503,418 Shares held | 3/31/2026 | View profile |
| Cole Pinnow Chief Commercial Officer | ▼ Sell | Tax Withholding | 216,650 Shares held | 12/17/2025 | View profile |
| Andrew R. Robbins President and CEO | ▼ Sell | Gift | 160,000 Shares held | 5/19/2026 | View profile |
| John Edward Robinson Chief Scientific Officer | ▼ Sell | Open Market | 140,002 Shares held | 12/26/2025 | View profile |
| Jessica Sachs Chief Medical Officer | ▼ Sell | Open Market | 133,938 Shares held | 12/26/2025 | View profile |
| John L. Green Chief Financial Officer | ▼ Sell | Open Market | 131,834 Shares held | 12/26/2025 | View profile |
| Evan Kearns Chief Legal Officer | ▼ Sell | Open Market | 109,398 Shares held | 12/26/2025 | View profile |
Transaction History
| Andrew R. Robbins | ▼ Sell | Gift | 160,000 | $0 | 5/19/2026 |
| Andrew R. Robbins | ▼ Sell | Gift | 160,000 | $0 | 5/19/2026 |
| Fairmount Funds Management LLC | ▼ Sell | Other | 7,000,000 | — | 3/31/2026 |
| Fairmount Funds Management LLC | ▼ Sell | Open Market | 7,000,000 | $242.6M | 3/31/2026 |
| Fairmount Funds Management LLC | ▼ Sell | Open Market | 3,500,000 | $127.4M | 1/22/2026 |
| Evan Kearns | ▼ Sell | Open Market | 65,000 | $2.5M | 12/26/2025 |
| John L. Green | ▼ Sell | Open Market | 77,000 | $3.0M | 12/26/2025 |
| Jessica Sachs | ▼ Sell | Open Market | 82,642 | $3.2M | 12/26/2025 |
| John Edward Robinson | ▼ Sell | Open Market | 90,000 | $3.5M | 12/26/2025 |
| John Edward Robinson | ▼ Sell | Tax Withholding | 139,998 | $5.5M | 12/17/2025 |
| Andrew R. Robbins | ▲ Buy | Grant | 185,000 | $0 | 12/17/2025 |
| Andrew R. Robbins | ▲ Buy | Grant | 840,000 | $0 | 12/17/2025 |
| Andrew R. Robbins | ▼ Sell | Tax Withholding | 367,497 | $14.5M | 12/17/2025 |
| Cole Pinnow | ▲ Buy | Grant | 50,000 | $0 | 12/17/2025 |
| Cole Pinnow | ▲ Buy | Grant | 214,000 | $0 | 12/17/2025 |
| Cole Pinnow | ▼ Sell | Tax Withholding | 94,800 | $3.7M | 12/17/2025 |
| Evan Kearns | ▲ Buy | Grant | 40,000 | $0 | 12/17/2025 |
| Evan Kearns | ▲ Buy | Grant | 260,000 | $0 | 12/17/2025 |
| Evan Kearns | ▼ Sell | Tax Withholding | 125,602 | $5.0M | 12/17/2025 |
| Jessica Sachs | ▲ Buy | Grant | 50,000 | $0 | 12/17/2025 |
| Jessica Sachs | ▲ Buy | Grant | 320,000 | $0 | 12/17/2025 |
| Jessica Sachs | ▼ Sell | Tax Withholding | 154,716 | $6.1M | 12/17/2025 |
| John L. Green | ▲ Buy | Grant | 50,000 | $0 | 12/17/2025 |
| John L. Green | ▲ Buy | Grant | 300,000 | $0 | 12/17/2025 |
| John L. Green | ▼ Sell | Tax Withholding | 145,007 | $5.7M | 12/17/2025 |
| John Edward Robinson | ▲ Buy | Grant | 50,000 | $0 | 12/17/2025 |
| John Edward Robinson | ▲ Buy | Grant | 320,000 | $0 | 12/17/2025 |
| Fairmount Funds Management LLC | ▲ Buy | Open Market | 2,777,777 | $25.0M | 7/10/2025 |
| Cole Pinnow | ▲ Buy | Open Market | 43,750 | $332K | 1/14/2025 |
| Fairmount Funds Management LLC | ▲ Buy | Option Exercise | 1,500,000 | — | 6/10/2024 |
| Fairmount Funds Management LLC | ▼ Sell | Other | 286,851 | — | 3/28/2024 |
| Fairmount Funds Management LLC | ▼ Sell | Other | 286,851 | — | 3/28/2024 |
| Fairmount Funds Management LLC | ▲ Buy | Grant | 1,166,666 | $8.7M | 2/16/2024 |
| Fairmount Funds Management LLC | ▲ Buy | Open Market | 800,000 | $9.6M | 6/9/2023 |
| Jessica Sachs | ▲ Buy | Grant | 622 | $5K | 6/30/2022 |
| Fairmount Funds Management LLC | ▲ Buy | Open Market | 1,200,000 | $9.9M | 6/16/2022 |
| Jessica Sachs | ▲ Buy | Grant | 674 | $5K | 12/31/2021 |